HBK Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,600,000
| Closed | -$1.21B | – | 757 |
|
|
2021
Q2 | $1.21B | Buy |
6,600,000
+875,000
| +15% | +$161M | 4.25% | 1 |
|
|
2021
Q1 | $875M | Buy |
5,725,000
+4,001,425
| +232% | +$612M | 3.96% | 1 |
|
|
2020
Q4 | $269M | Buy |
+1,723,575
| New | +$269M | 1.76% | 8 |
|
|
2019
Q2 | – | Sell |
-1,948
| Closed | -$263K | – | 901 |
|
|
2019
Q1 | $263K | Sell |
1,948
-148,757
| -99% | -$20.1M | ﹤0.01% | 750 |
|
|
2018
Q4 | $14.7M | Buy |
+150,705
| New | +$14.7M | 0.16% | 85 |
|
|
2018
Q3 | – | Sell |
-29,869
| Closed | -$3.71M | – | 1257 |
|
|
2018
Q2 | $3.71M | Sell |
29,869
-45,171
| -60% | -$5.61M | 0.02% | 285 |
|
|
2018
Q1 | $8.36M | Buy |
75,040
+72,421
| +2,765% | +$8.07M | 0.06% | 158 |
|
|
2017
Q4 | $313K | Buy |
+2,619
| New | +$313K | ﹤0.01% | 782 |
|
|
2016
Q3 | – | Sell |
-2,052
| Closed | -$240K | – | 1011 |
|
|
2016
Q2 | $240K | Buy |
+2,052
| New | +$240K | ﹤0.01% | 825 |
|
|
2015
Q2 | – | Sell |
-65,600
| Closed | -$11.4M | – | 1084 |
|
|
2015
Q1 | $11.4M | Sell |
65,600
-24,120
| -27% | -$4.18M | 0.11% | 83 |
|
|
2014
Q4 | $16.6M | Buy |
89,720
+72,672
| +426% | +$13.4M | 0.2% | 52 |
|
|
2014
Q3 | $2.83M | Sell |
17,048
-89,652
| -84% | -$14.9M | 0.04% | 242 |
|
|
2014
Q2 | $16.7M | Sell |
106,700
-20,800
| -16% | -$3.25M | 0.34% | 34 |
|
|
2014
Q1 | $19.4M | Buy |
127,500
+108,600
| +575% | +$16.5M | 0.36% | 28 |
|
|
2013
Q4 | $2.52M | Buy |
18,900
+16,900
| +845% | +$2.25M | 0.05% | 224 |
|
|
2013
Q3 | $232K | Sell |
2,000
-34,282
| -94% | -$3.98M | ﹤0.01% | 766 |
|
|
2013
Q2 | $3.35M | Buy |
+36,282
| New | +$3.35M | 0.05% | 173 |
|